EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Direct Comparison of Two Commercially Available Pulsed Field Ablation Systems for Atrial Fibrillation; Procedure Characteristics and Acute Outcomes

Bob G S Abeln iD, Marisa van der Graaf iD, Dan L Musat iD, Melanie A Gunawardene iD, Devi G Nair, Bradley P Knight, Bradley Wilsmore iD, Max Liebregts, Vincent F van Dijk iD, Maurits C E F Wijffels, Jippe C Balt iD, Suneet Mittal iD und 5 weitere

Journal of Cardiovascular Electrophysiology · 2025-08 · 36 (8) · 1957-1965

DOI: 10.1111/jce.16761 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 12.06.2025. Verfasst von Bob G S Abeln und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiac Catheters, Catheter Ablation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are few comparative studies on the everyday clinical outcomes of commercially available pulsed field ablation (PFA) systems for atrial fibrillation (AF).

Objective

This study evaluates the acute efficacy and safety outcomes of the FARAPULSE™ (pentaspline catheter) and PulseSelect™ (circular catheter) system.

Methods

International, multicenter, registry on patients with paroxysmal or persistent AF, undergoing a first ablation using either PFA system between January 29th, 2024 and September 1st, 2024. Primary endpoints were electrical isolation of ablation targets, procedural characteristics and freedom from major adverse events within 30 days postprocedure.

Results

A total of 402 patients were enrolled at the six participating centers, of whom 56.5% were treated with the pentaspline ablation‐catheter. Acute procedural efficacy was 100% for both groups. Use of the pentaspline ablation‐catheter was associated with significantly shorter procedural times (36.0 min [IQR 31.0; 44.0] vs. 49.0 min [IQR 41.5;76.0]) compared to the circular ablation‐catheter ( p < 0.001). Major adverse events were scarce and not different between cohorts. Two patients (0.5%) experienced a stroke and one patient (0.2%) had a serious vascular access site complication. One patient had a transient ischemic attack (0.2%). Minor vascular access site complications were more common in the pentaspline catheter group (11.9% vs. 1.1%, p < 0.001).

Conclusions

This study showed excellent acute efficacy and safety for both PFA‐systems. Our findings reveal shorter procedural times with the pentaspline catheter, less minor access site complications with the circular catheter, and several procedural differences between the ablation systems, often driven by operator choice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiac CathetersCatheter AblationAgedFemaleHumansMaleMiddle AgedAction PotentialsEquipment DesignHeart RateOperative TimeRegistriesRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

atrial fibrillationcatheter ablationefficacypulmonary vein isolationpulsed field ablationsafety

Autor:innen und Institutionen

  • Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.
  • Department of Cardiology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Snyder Center for Comprehensive Atrial Fibrillation, Valley Health System, Paramus, New Jersey, USA.
  • Department of Cardiology and Intensive Care medicine, Asklepios St. Georg Clinic, Hamburg, Germany.
  • Department of Cardiac Electrophysiology, St. Bernards Medical Center, Jonesboro, Arkansas, USA.
  • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Bob G S Abeln, Marisa van der Graaf, Dan L Musat, Melanie A Gunawardene, Bradley Wilsmore, Vincent F van Dijk, Jippe C Balt, Suneet Mittal, Nishant Verma, Lucas V A Boersma

Zitieren

APA

Abeln, B. G. S., van der Graaf, M., Musat, D. L., Gunawardene, M. A., Nair, D. G., Knight, B. P., Wilsmore, B., Liebregts, M., van Dijk, V. F., Wijffels, M. C. E. F., Balt, J. C., Mittal, S., Willems, S., Verma, N., Peigh, G., Malaty, M. M., & Boersma, L. V. A. (2025). Direct Comparison of Two Commercially Available Pulsed Field Ablation Systems for Atrial Fibrillation; Procedure Characteristics and Acute Outcomes. Journal of Cardiovascular Electrophysiology, 36(8), 1957-1965. https://doi.org/10.1111/jce.16761

Vancouver

Abeln BGS, van der Graaf M, Musat DL, Gunawardene MA, Nair DG, Knight BP, et al. Direct Comparison of Two Commercially Available Pulsed Field Ablation Systems for Atrial Fibrillation; Procedure Characteristics and Acute Outcomes. Journal of Cardiovascular Electrophysiology. 2025;36(8):1957-1965. doi:10.1111/jce.16761

BibTeX
@article{Abeln2025,
  author = {Abeln, Bob G S and van der Graaf, Marisa and Musat, Dan L and Gunawardene, Melanie A and Nair, Devi G and Knight, Bradley P and Wilsmore, Bradley and Liebregts, Max and van Dijk, Vincent F and Wijffels, Maurits C E F and Balt, Jippe C and Mittal, Suneet and Willems, Stephan and Verma, Nishant and Peigh, Graham and Malaty, Michael M and Boersma, Lucas V A},
  title = {Direct Comparison of Two Commercially Available Pulsed Field Ablation Systems for Atrial Fibrillation; Procedure Characteristics and Acute Outcomes},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  volume = {36},
  number = {8},
  pages = {1957--1965},
  doi = {10.1111/jce.16761}
}
Kostenlos starten →